Huaxin Zhou

1.1k total citations · 2 hit papers
42 papers, 756 citations indexed

About

Huaxin Zhou is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Huaxin Zhou has authored 42 papers receiving a total of 756 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 11 papers in Cancer Research and 8 papers in Oncology. Recurrent topics in Huaxin Zhou's work include Immune Response and Inflammation (5 papers), HER2/EGFR in Cancer Research (4 papers) and Lung Cancer Treatments and Mutations (4 papers). Huaxin Zhou is often cited by papers focused on Immune Response and Inflammation (5 papers), HER2/EGFR in Cancer Research (4 papers) and Lung Cancer Treatments and Mutations (4 papers). Huaxin Zhou collaborates with scholars based in China, United States and Germany. Huaxin Zhou's co-authors include Bin Jin, Xiangyu Zhai, Huizhi Wang, David A. Scott, Richard J. Lamont, Zhijia Xia, Gang Du, Tong Xia, Xiaoxian Duan and Zi‐Jian Lan and has published in prestigious journals such as The Journal of Immunology, Analytical Chemistry and Oncogene.

In The Last Decade

Huaxin Zhou

39 papers receiving 743 citations

Hit Papers

KIF18A inactivates hepatic stellate cells and alleviates ... 2024 2026 2025 2024 2024 20 40 60

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Huaxin Zhou China 16 397 166 151 150 104 42 756
Lijing Wang China 20 668 1.7× 182 1.1× 299 2.0× 178 1.2× 126 1.2× 66 1.2k
Hui-Wen Cheng Taiwan 18 523 1.3× 161 1.0× 290 1.9× 192 1.3× 87 0.8× 27 929
Maryam Rezaei Iran 19 450 1.1× 96 0.6× 261 1.7× 137 0.9× 63 0.6× 52 840
Remya Raja India 15 361 0.9× 120 0.7× 175 1.2× 161 1.1× 64 0.6× 29 807
Yiqing Zhao China 16 628 1.6× 173 1.0× 125 0.8× 196 1.3× 52 0.5× 37 901
Li-Yuan Bai Taiwan 17 466 1.2× 102 0.6× 99 0.7× 150 1.0× 89 0.9× 42 869
Masahiko Shibazaki Japan 18 581 1.5× 165 1.0× 310 2.1× 188 1.3× 59 0.6× 33 1.1k
Lin An China 12 377 0.9× 128 0.8× 118 0.8× 65 0.4× 113 1.1× 51 682

Countries citing papers authored by Huaxin Zhou

Since Specialization
Citations

This map shows the geographic impact of Huaxin Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Huaxin Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Huaxin Zhou more than expected).

Fields of papers citing papers by Huaxin Zhou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Huaxin Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Huaxin Zhou. The network helps show where Huaxin Zhou may publish in the future.

Co-authorship network of co-authors of Huaxin Zhou

This figure shows the co-authorship network connecting the top 25 collaborators of Huaxin Zhou. A scholar is included among the top collaborators of Huaxin Zhou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Huaxin Zhou. Huaxin Zhou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhou, Huaxin, Haohao Fu, Xueguang Shao, & Wensheng Cai. (2025). Identification of novel inhibitors for epidermal growth factor receptor tyrosine kinase using absolute binding free-energy simulations. International Journal of Biological Macromolecules. 304(Pt 2). 140989–140989. 2 indexed citations
2.
Du, Gang, Zhaochen Jiang, Tong Xia, et al.. (2024). lincRNA00907 promotes NASH progression by targeting miRNA-942-5p/TAOK1. Aging. 16(8). 6868–6882.
4.
Yang, Mengfan, Xiangyu Zhai, Xinyu Yang, et al.. (2024). Integrated multi-omic analysis identifies fatty acid binding protein 4 as a biomarker and therapeutic target of ischemia–reperfusion injury in steatotic liver transplantation. Cellular and Molecular Life Sciences. 81(1). 83–83. 5 indexed citations
5.
Zhang, Hao, Zhijia Xia, Huaxin Zhou, et al.. (2024). KIF18A inactivates hepatic stellate cells and alleviates liver fibrosis through the TTC3/Akt/mTOR pathway. Cellular and Molecular Life Sciences. 81(1). 61 indexed citations breakdown →
6.
Tian, Ke, Ying Deng, Zhipeng Li, Huaxin Zhou, & Hui Yao. (2023). AKR1B10 inhibits the proliferation and metastasis of hepatocellular carcinoma cells by regulating the PI3K/AKT pathway. Oncology Letters. 27(1). 18–18. 7 indexed citations
7.
Li, Zhipeng, Huaxin Zhou, Zhijia Xia, et al.. (2023). HMGA1 augments palbociclib efficacy via PI3K/mTOR signaling in intrahepatic cholangiocarcinoma. Biomarker Research. 11(1). 33–33. 40 indexed citations
9.
Zhou, Huaxin, Haohao Fu, Han Liu, Xueguang Shao, & Wensheng Cai. (2022). Uncovering the Mechanism of Drug Resistance Caused by the T790M Mutation in EGFR Kinase From Absolute Binding Free Energy Calculations. Frontiers in Molecular Biosciences. 9. 922839–922839. 8 indexed citations
10.
11.
Yi, Xinyao, Saisai Wang, Huaxin Zhou, et al.. (2021). Construction of graphene quantum dots-decorated EGFR cell membrane chromatography for screening active components from Peucedanum praeruptorum Dunn. Analytical and Bioanalytical Chemistry. 413(7). 1917–1927. 9 indexed citations
12.
Pan, Xiaoyan, Liyuan Liang, Jin Wang, et al.. (2018). Discovery of novel anti-angiogenesis agents. Part 10: Multi-target inhibitors of VEGFR-2, Tie-2 and EphB4 incorporated with 1,2,3-triazol. European Journal of Medicinal Chemistry. 163. 1–9. 20 indexed citations
13.
Shan, Yuanyuan, Qingqing Zhang, Huaxin Zhou, et al.. (2018). Discovery of novel anti-angiogenesis agents. Part 9: Multiplex inhibitors suppressing compensatory activations of RTKs. European Journal of Medicinal Chemistry. 164. 440–447. 11 indexed citations
14.
Lan, Zi‐Jian, X. Li, Huaxin Zhou, et al.. (2017). Selective deletion of Pten in theca-interstitial cells leads to androgen excess and ovarian dysfunction in mice. Molecular and Cellular Endocrinology. 444. 26–37. 26 indexed citations
15.
Sears, Catherine R., Huaxin Zhou, Matthew J. Justice, et al.. (2017). Xeroderma Pigmentosum Group C Deficiency Alters Cigarette Smoke DNA Damage Cell Fate and Accelerates Emphysema Development. American Journal of Respiratory Cell and Molecular Biology. 58(3). 402–411. 18 indexed citations
16.
Lan, Zi‐Jian, Sheng Zhang, Xian Li, et al.. (2016). GGNBP2 acts as a tumor suppressor by inhibiting estrogen receptor α activity in breast cancer cells. Breast Cancer Research and Treatment. 158(2). 263–276. 16 indexed citations
17.
Li, Shengqiang, Xian Li, Huaxin Zhou, et al.. (2016). Ggnbp2 Is Essential for Pregnancy Success via Regulation of Mouse Trophoblast Stem Cell Proliferation and Differentiation1. Biology of Reproduction. 94(2). 41–41. 12 indexed citations
18.
Zhou, Huaxin, Yi Kang, Xiaoju Zhang, et al.. (2015). Syk negatively regulates TLR4-mediated IFNβ and IL-10 production and promotes inflammatory responses in dendritic cells. Biochimica et Biophysica Acta (BBA) - General Subjects. 1860(3). 588–598. 26 indexed citations
19.
Wang, Huizhi, Jonathan R. Brown, Shuang Liang, et al.. (2013). The Role of JAK-3 in Regulating TLR-Mediated Inflammatory Cytokine Production in Innate Immune Cells. The Journal of Immunology. 191(3). 1164–1174. 64 indexed citations
20.
Li, Zili, et al.. (2008). Reduced white fat mass in adult mice bearing a truncated Patched 1. International Journal of Biological Sciences. 4(1). 29–36. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026